Evidence map›Paper›PMID 42921222›Full record

ArticleRSC medicinal chemistry2026

Strategic development of benzimidazole-derived glycosidase modulators for antihyperglycemic intervention: a comprehensive medicinal study integrating molecular docking, biological evaluation,

Zanib Fiaz, Shoaib Khan, Tayyiaba Iqbal, Khurram Shoaib, Masi A Almalki, Faez Alotaibi, Khasan Kayumov, Souhir Abid, Majdi Abid, Sobhi M Gomha and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zanib FiazDepartment of Chemistry, Abbottabad University of Science and Technology Abbottabad-22500 Pakistan shoaibkhanswati@gmail.com.
Shoaib KhanDepartment of Chemistry, Abbottabad University of Science and Technology Abbottabad-22500 Pakistan shoaibkhanswati@gmail.com.ORCID https://orcid.org/0000-0001-5404-0954
Tayyiaba IqbalDepartment of Chemistry, Abbottabad University of Science and Technology Abbottabad-22500 Pakistan shoaibkhanswati@gmail.com.
Khurram ShoaibDepartment of Chemistry, Abbottabad University of Science and Technology Abbottabad-22500 Pakistan shoaibkhanswati@gmail.com.
Masi A AlmalkiDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University Taif Saudi Arabia.
Faez AlotaibiDepartment of Chemistry, College of Science, Qassim University Buraydah Saudi Arabia.
Khasan KayumovNational University of Uzbekistan named after Mirza Ulugbek Tashkent Uzbekistan.
Souhir AbidDepartment of Chemistry, College of Science, Jouf University P.O. Box 2014 Sakaka Aljouf Kingdom of Saudi Arabia.
Majdi AbidDepartment of Chemistry, College of Science, Jouf University P.O. Box 2014 Sakaka Aljouf Kingdom of Saudi Arabia.
Sobhi M GomhaDepartment of Chemistry, Faculty of Science, Islamic University of Madinah Madinah 42351 Saudi Arabia smgomha@iu.edu.sa.ORCID https://orcid.org/0000-0002-7739-2837
Magdi E A ZakiDepartment of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current

Identifiers

PMID42921222
PMCPMC13693544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.